EUVIMEDEUVIMED entdecken
Crossref

A Noninvasive Nanoeyedrop Therapy for the Inhibition of Uveal Melanoma: Tetrahedral Framework Nucleic Acid–Based Bioswitchable MicroRNA Delivery System

Zhou Jiang, Yichen Yang, Ziqi Yue, Ye Chen, Long Bai, Ruiqing Wang, Songhang Li, Yunfeng Lin iD

ACS Nano · 22.04.2025 · 19 (15) · 14756-14769

DOI: 10.1021/acsnano.4c16427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 10.04.2025. Verfasst von Zhou Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of S…. Hauptthemen laut MEDLINE: MicroRNAs, Uveal Neoplasms, Melanoma, Nucleic Acids. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Sichuan University, Health Commission of Sichuan Province, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uveal melanoma (UM) is the most prevalent primary intraocular malignancy, exhibiting pronounced invasive characteristics and a dismal prognosis. Conventional therapeutic modalities, including radiotherapy, laser therapy, and surgery, are frequently invasive and can lead to complications, underscoring the need for the development of efficacious, safe, and noninvasive therapeutic approaches. This study investigated a tetrahedral framework nucleic acid (tFNA)-based bioswitchable microRNA (miRNA) delivery system, designated BiRDS, engineered for the inhibition of UM through the use of miRNA suppressors via noninvasive eyedrops. The BiRDS construct exhibited a tetrahedral structure, which was small in size, easily synthesizable, stable, and biosafe, and was able to efficiently carry miR-30a-5p into UM cells. Functionally, BiRDS was observed to inhibit the proliferation, migration, and invasion of UM cells while promoting apoptosis through the miR-30a-5p/E2F7 axis. It is noteworthy that BiRDS nanoeyedrops were able to penetrate the complex ocular barrier structure and reach the fundus, thereby inhibiting the growth of UM in a xenograft model. As a patient-friendly, eyedrop-based miRNA delivery system, BiRDS not only inhibited UM without enucleation of the eyeball but was also expected to improve patient compliance and quality of life while providing a safer alternative for ocular drug administration. This work substantiates BiRDS nanoeyedrops as a potential paradigm shift in the local treatment of early UM, facilitating its application in treating other ocular diseases via miRNA therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsUveal NeoplasmsMelanomaNucleic AcidsAntineoplastic AgentsHumansUveal MelanomaAnimalsMiceCell ProliferationCell Line, TumorApoptosisCell Movement

Stichwörter der Autor:innen

eyedropsmiRNA delivery systemsmiRNA-based gene therapynoninvasivetetrahedral framework nucleic acidsuveal melanoma

Substanzen

MicroRNAsNucleic AcidsAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China.
  • Sichuan Provincial Engineering Research Center of Oral Biomaterials, Chengdu 610041, Sichuan, China.
  • National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai 200240, China.

ORCID-Profile: Yunfeng Lin

Förderung

  • Sichuan University
  • Health Commission of Sichuan Province
  • China Postdoctoral Science Foundation
  • Sichuan Province Youth Science and Technology Innovation Team
  • National Natural Science Foundation of China
  • Sichuan Provincial Science and Technology Support Program
  • West China Hospital of Stomatology, Sichuan University

Zitieren

APA

Jiang, Z., Yang, Y., Yue, Z., Chen, Y., Bai, L., Wang, R., Li, S., & Lin, Y. (2025). A Noninvasive Nanoeyedrop Therapy for the Inhibition of Uveal Melanoma: Tetrahedral Framework Nucleic Acid–Based Bioswitchable MicroRNA Delivery System. ACS Nano, 19(15), 14756-14769. https://doi.org/10.1021/acsnano.4c16427

Vancouver

Jiang Z, Yang Y, Yue Z, Chen Y, Bai L, Wang R, et al. A Noninvasive Nanoeyedrop Therapy for the Inhibition of Uveal Melanoma: Tetrahedral Framework Nucleic Acid–Based Bioswitchable MicroRNA Delivery System. ACS Nano. 2025;19(15):14756-14769. doi:10.1021/acsnano.4c16427

BibTeX
@article{Jiang2025,
  author = {Jiang, Zhou and Yang, Yichen and Yue, Ziqi and Chen, Ye and Bai, Long and Wang, Ruiqing and Li, Songhang and Lin, Yunfeng},
  title = {A Noninvasive Nanoeyedrop Therapy for the Inhibition of Uveal Melanoma: Tetrahedral Framework Nucleic Acid–Based Bioswitchable MicroRNA Delivery System},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {15},
  pages = {14756--14769},
  doi = {10.1021/acsnano.4c16427}
}
Kostenlos starten →